Average P/FCF Ratio

← P/FCF Ratio

The current P/FCF ratio is 5.62 as of Monday, October 5, 2026, shown against its trailing averages.

PCRX P/FCF Ratio

PCRX Average P/FCF Ratio

PCRX P/FCF Ratio Averages

P/FCF RATIO TODAY

5.62

P/FCF RATIO TTM

7.51

P/FCF RATIO 3Y

7.85

P/FCF RATIO 5Y

13.61

P/FCF RATIO 10Y

32.74

P/FCF RATIO 15Y

N/A

P/FCF RATIO 20Y

N/A

About Pacira BioSciences, Inc.

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.

Brisbane, CA

827 employees

www.pacira.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Frank D. Lee

View full financials